Prot #R668‐AD‐2131: Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children with Moderate/Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date8/28/2312/31/25

Funding

  • Regeneron Pharmaceuticals, Inc. (Prot# R668-AD-2131)